Home/Filings/SCHEDULE 13G/0001193125-25-282690
SCHEDULE 13G//SEC Filing

SELLAS Life Sciences Group, Inc. SCHEDULE 13G

Accession 0001193125-25-282690

CIK 0001491072other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 3:15 PM ET

Size

33.3 KB

Accession

0001193125-25-282690

Issuer

Anson Funds Management LP

CIK 0001491072

Entity typeother
IncorporatedTX

Related Parties

1
  • filerCIK 0001491072

Filing Metadata

Form type
SCHEDULE 13G
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 3:15 PM ET
Size
33.3 KB